These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10842475)

  • 1. [Therapy of hypothyroidism. T4 or better T3/T4?].
    Meng W
    MMW Fortschr Med; 2000 Apr; 142(15):39-40. PubMed ID: 10842475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of thyroid hormones in therapy of psychiatric illnesses].
    Weissel M
    Acta Med Austriaca; 1999; 26(4):129-31. PubMed ID: 10526631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of hypothyroidism therapy with thyroid hormone].
    Fang L; Tan T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):396-9. PubMed ID: 15884564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-T4 and L-T3 combined treatment vs L-T4 alone.
    Wiersinga WM
    Ann Endocrinol (Paris); 2007 Sep; 68(4):216-9. PubMed ID: 17689474
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined T4 and T3 therapy.
    Utiger RD
    Thyroid; 2004 Oct; 14(10):872. PubMed ID: 15588389
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioidentical thyroid replacement therapy in practice: Delivering a physiologic T4:T3 ratio for improved patient outcomes with the Listecki-Snyder protocol.
    Snyder S; Listecki RE
    Int J Pharm Compd; 2012; 16(5):376-80. PubMed ID: 23072197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hypothyroidism].
    Haug E
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):935-7. PubMed ID: 12082840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy of thyroxine and triiodothyronine in hypothyroid patients].
    Nygaard B; Røder ME; Karmisholt J; Kristensen JK
    Ugeskr Laeger; 2018 May; 180(19):. PubMed ID: 29761770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does substitution of T4 with T3 plus T4 for T4 replacement improve depressive symptoms in patients with hypothyroidism?
    Joffe RT; Sawka AM; Marriott MJ; MacQueen GM; Gernstein HC
    Ann N Y Acad Sci; 2004 Dec; 1032():287-8. PubMed ID: 15677430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a combination of 1-T 4 and 1-T 3 in the treatment of thyroid insufficiency].
    Ermans AM; Camus M
    Rev Fr Endocrinol Clin; 1971; 12(4):315-24. PubMed ID: 4113804
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy.
    Appelhof BC; Peeters RP; Wiersinga WM; Visser TJ; Wekking EM; Huyser J; Schene AH; Tijssen JG; Hoogendijk WJ; Fliers E
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6296-9. PubMed ID: 16144953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosage recommendations for combination regimen of thyroxine and 3,5,3'-triiodothyronine.
    Blanchard KR
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1486-7; author reply 1487-8. PubMed ID: 15001655
    [No Abstract]   [Full Text] [Related]  

  • 14. T4 + T3 combination therapy: any progress?
    Wiersinga WM
    Endocrine; 2019 Oct; 66(1):70-78. PubMed ID: 31617166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined substitution treatment with thyroxine and triiodothyronine?].
    Frey H
    Tidsskr Nor Laegeforen; 1971 Jan; 91(3):222. PubMed ID: 5539964
    [No Abstract]   [Full Text] [Related]  

  • 16. Reassessment of combined LT4 and LT3 treatment for hypothyroidism: the prospects for slow-release T3 preparations.
    Duntas LH
    Hormones (Athens); 2005; 4(2):108-10. PubMed ID: 16613813
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic experience with a new combination preparation of the thyroid hormones L-thyroxine and L-triiodothyronine].
    Horster FA; Oberdisse K; Reinwein D
    Verh Dtsch Ges Inn Med; 1968; 74():1203-6. PubMed ID: 5714276
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis.
    Joffe RT; Brimacombe M; Levitt AJ; Stagnaro-Green A
    Psychosomatics; 2007; 48(5):379-84. PubMed ID: 17878495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hypothyroidism.
    Kristensen L; Nygaard B
    Clin Evid; 2002 Jun; (7):548-54. PubMed ID: 12230680
    [No Abstract]   [Full Text] [Related]  

  • 20. Printing T
    Alomari M; Vuddanda PR; Trenfield SJ; Dodoo CC; Velaga S; Basit AW; Gaisford S
    Int J Pharm; 2018 Oct; 549(1-2):363-369. PubMed ID: 30063938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.